×
-0.0991150442477877 -0.0991150442477877 -0.0991150442477877 -0.0991150442477877 -0.0477876106194691 -0.0442477876106195 -0.0115044247787611 -0.0584070796460177
Stockreport

Arcturus Therapeutics appoints Dr. Christine Esau as VP of R&D [Seeking Alpha]

ARCTURUS THERAPEUTICS LTD (ARCT)  More Company Research Source: Seeking Alpha
PDF Arcturus Therapeutics appoints Dr. Christine Esau as VP of R&DArcturus Therapeutics (NASDAQ:ARCT) hasappointed Dr. Christine Esau, Senior Director of Translational Research, as Vice President of Research and Development, effective immediately.Dr. Esau prior to joining Arcturus in 2015, was lead biologist at Ionis Pharmaceuticals and Regulus Therapeutics and served as Chief Scientific Officer of AptamiR Therapeutics.Also, Dr. Pad Chivukula is stepping down as Chief Scientific Officer and Chief Operating Officer and will serve as a Scientific Advisor to the Company.Click to subscribe to real-time analytics on ARCTNow read:Carl Zeiss Meditec AG ADR 2018 Q3 - Results - Earnings Call Slides » [Read more]

IMPACT SNAPSHOT EVENT TIME: ARCT
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS